{"id":627,"date":"2021-09-30T14:49:00","date_gmt":"2021-09-30T18:49:00","guid":{"rendered":"https:\/\/www.napra.ca\/?p=627"},"modified":"2022-09-14T12:02:35","modified_gmt":"2022-09-14T16:02:35","slug":"precisions-sur-la-classification-de-la-mupirocine","status":"publish","type":"post","link":"https:\/\/www.napra.ca\/fr\/precisions-sur-la-classification-de-la-mupirocine\/","title":{"rendered":"Pr\u00e9cisions sur la classification de la mupirocine"},"content":{"rendered":"\n

L\u2019Association nationale des organismes de r\u00e9glementation de la pharmacie (ANORP) a re\u00e7u des questions sur la classification de la mupirocine. La mupirocine<\/a> est class\u00e9e dans l\u2019annexe I des Annexes nationales de m\u00e9dicaments (ANM).<\/p>\n\n\n\n

Le\u00a0Comit\u00e9 consultatif national sur les annexes\u00a0de m\u00e9dicaments\u00a0(CCNAM)<\/a>\u00a0est un\u00a0comit\u00e9 consultatif\u00a0d\u2019experts\u00a0qui examine les\u00a0demandes de classification que re\u00e7oit l\u2019ANORP et formule des recommandations de classification de m\u00e9dicament aux ANM.\u00a0Le mod\u00e8le de formulation des recommandations de classification des m\u00e9dicaments suit un \u00ab principe en cascade \u00bb selon lequel les m\u00e9dicaments font l\u2019objet d\u2019une \u00e9valuation en\u00a0fonction des\u00a0facteurs de classification des m\u00e9dicaments<\/a>\u00a0pr\u00e9cis\u00a0(le document en lien est en anglais)<\/em>. Tout m\u00e9dicament fait premi\u00e8rement l\u2019objet d\u2019une \u00e9valuation en fonction des facteurs de l\u2019annexe I. Si les facteurs applicables sont suffisants, le m\u00e9dicament reste\u00a0class\u00e9\u00a0dans\u00a0cette annexe. Sinon, on \u00e9value le m\u00e9dicament en fonction des facteurs de l\u2019annexe II puis, si cela se justifie, en fonction des facteurs de l\u2019annexe III. Si le m\u00e9dicament ne r\u00e9pond aux facteurs d\u2019aucune annexe, il devient \u00ab hors annexe \u00bb (la\u00a0quatri\u00e8me cat\u00e9gorie).<\/p>\n\n\n\n

Conform\u00e9ment \u00e0 ce principe en cascade, il est possible, quoique plut\u00f4t rare, que l\u2019ANORP inscrive un\u00a0produit\u00a0\u00e0 l\u2019annexe I\u00a0alors que ce produit avait \u00e9t\u00e9 class\u00e9 dans la cat\u00e9gorie des\u00a0m\u00e9dicaments sans ordonnance par Sant\u00e9 Canada. La\u00a0mupirocine\u00a0est un exemple d’ingr\u00e9dient\u00a0m\u00e9dicamenteux\u00a0que Sant\u00e9 Canada a class\u00e9\u00a0dans la cat\u00e9gorie des m\u00e9dicaments sans ordonnance\u00a0mais\u00a0qui\u00a0a \u00e9t\u00e9 inscrit \u00e0 l’annexe I des ANM.\u00a0Par cons\u00e9quent,\u00a0elle n\u00e9cessite une ordonnance dans les\u00a0provinces et territoires qui appliquent les ANM<\/a>.\u00a0Cet\u00a0exemple\u00a0d\u00e9crit une situation o\u00f9\u00a0la classification\u00a0d’une substance\u00a0dans les ANM\u00a0est plus restrictive\u00a0que celle requise par la l\u00e9gislation f\u00e9d\u00e9rale\u00a0en termes de conditions de vente.\u00a0Les ANM\u00a0peuvent \u00eatre\u00a0plus\u00a0restrictives,\u00a0mais jamais\u00a0moins restrictives,\u00a0que la l\u00e9gislation f\u00e9d\u00e9rale.<\/strong><\/p>\n\n\n\n

Un examen par le CCNAM \u2013 pour modifier potentiellement les conditions de vente de la mupirocine \u2013 pourrait \u00eatre men\u00e9 si une demande de classification de m\u00e9dicament (de la part d\u2019un promoteur ou d\u2019un fabricant) viendrait \u00e0 \u00eatre d\u00e9pos\u00e9e \u00e0 cet effet aupr\u00e8s de l’ANORP.<\/p>\n\n\n\n

De plus, puisque les ANM sont mises en \u0153uvre de mani\u00e8re l\u00e9g\u00e8rement diff\u00e9rente selon la province ou le territoire, il pourrait y avoir des exceptions \u00e0 la classification de certains m\u00e9dicaments dans certaines provinces ou certains territoires (de plus amples renseignements sont disponibles sur le\u00a0site Web de l\u2019ANORP<\/a>). Il est conseill\u00e9 de s\u2019adresser \u00e0 l\u2019organisme de r\u00e9glementation de la pharmacie<\/a>\u00a0(habituellement l\u2019ordre des pharmaciens) de la province ou du territoire en question pour obtenir des renseignements pr\u00e9cis au sujet des r\u00e8glements qui s\u2019appliquent \u00e0 la classification de m\u00e9dicaments dans cette province ou ce territoire.<\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019Association nationale des organismes de r\u00e9glementation de la pharmacie (ANORP) a re\u00e7u des questions sur la classification de la mupirocine. La mupirocine est class\u00e9e dans l\u2019annexe I des Annexes nationales de m\u00e9dicaments (ANM). Le\u00a0Comit\u00e9 […]<\/p>\n","protected":false},"author":3,"featured_media":625,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"class_list":["post-627","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mises-a-jour-des-anm"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",660,440,false],"thumbnail":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR-150x150.png",150,150,true],"medium":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR-300x200.png",300,200,true],"medium_large":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",660,440,false],"large":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",660,440,false],"1536x1536":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",660,440,false],"2048x2048":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",660,440,false],"gform-image-choice-sm":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",300,200,false],"gform-image-choice-md":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",400,267,false],"gform-image-choice-lg":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-FAQ-FR.png",600,400,false]},"uagb_author_info":{"display_name":"Stephanie Smith","author_link":"https:\/\/www.napra.ca\/fr\/author\/stephflow\/"},"uagb_comment_info":0,"uagb_excerpt":"L\u2019Association nationale des organismes de r\u00e9glementation de la pharmacie (ANORP) a re\u00e7u des questions sur la classification de la mupirocine. La mupirocine est class\u00e9e dans l\u2019annexe I des Annexes nationales de m\u00e9dicaments (ANM). Le\u00a0Comit\u00e9 […]","_links":{"self":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts\/627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/comments?post=627"}],"version-history":[{"count":0,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts\/627\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/media\/625"}],"wp:attachment":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/media?parent=627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/categories?post=627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/tags?post=627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}